DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
HYDROCODONE BITARTRATE; IBUPROFEN
Search structure
Trade Names:
HYDROCODONE BITARTRATE AND IBUPROFEN
REPREXAIN
VICOPROFEN
Status:
Approved
Entry Type:
Combination
Molecule Category:
Mixture
Compounds in the Mixture:
HYDROCODONE BITARTRATE
IBUPROFEN
Related Entries
Salt
HYDROCODONE BITARTRATE
Parent
IBUPROFEN
Adverse Reactions
SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
23.26
Nervous system disorders
13.54
Psychiatric disorders
13.19
Product issues
11.81
Injury, poisoning and procedural complications
7.64
Gastrointestinal disorders
5.9
Musculoskeletal and connective tissue disorders
5.56
Investigations
4.86
Immune system disorders
2.78
Vascular disorders
2.78
Cardiac disorders
2.08
CONTENTS
Structure
Related Entries
Adverse Reactions
×
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Exact
Similarity
SubStructure
Threshold (%) >=
70